SGP — SpyGlass Pharma, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1778922 ·
Last close
$22.53
Market Cap
$753.25M
52W High
$25.77
52W Low
$17.06
ADV30
159,120
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -15,409,000 | -13,818,000 | 258,386,000 | 238,902,000 | 8,274,000 |
| Dec 2025 | 0 | — | -13,627,711 | -12,555,228 | 115,866,000 | 96,358,000 | 214,703,000 |
| Sep 2025 | — | — | — | — | 127,012,143 | 106,006,749 | 214,236,927 |
| Mar 2025 | 0 | — | -7,423,000 | -8,823,000 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-37,328,736
Investing CF
$2,786,047
Financing CF
$207,103,923
CapEx
$-1,699,466
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-1.18
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-118,548,000
Inventory
—
Receivables
$653,000
ST Investments
$12,100,000
EBIT TTM
$-44,213,613
Pretax Income TTM
$-43,595,494
Interest Exp TTM
—
Analysts
5
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -41,449,000 | -39,869,000 | 115,866,000 | 214,703,000 | — | -32,701,000 |
| Dec 2024 | 0 | -27,064,000 | -29,164,000 | 23,318,000 | 83,792,000 | — | -22,027,000 |
| Dec 2023 | 0 | -14,230,365 | -13,318,990 | 41,149,466 | 74,134,984 | — | -12,277,733 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.70
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AVR | Anteris Technologies Global Corp. | $763.16M | $7.84 | — |
| SIBN | SI-BONE, Inc. | $787.64M | $17.76 | — |
| SSII | SS Innovations International, Inc. | $796.52M | $3.98 | — |
| CBLL | Ceribell, Inc. | $671.21M | $17.69 | — |
| INMD | InMode Ltd. | $870.26M | $15.14 | — |
News headlines (Yahoo Finance, 1h cache)
SpyGlass Pharma Appoints Shannon Treviño as General Counsel
2026-06-15 12:00 · Yahoo
SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing
2026-06-02 12:00 · Yahoo
SpyGlass Pharma to Participate in Upcoming Investor Conferences
2026-05-21 12:00 · Yahoo
SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System
2026-05-18 12:00 · Yahoo
SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
2026-05-14 20:05 · Yahoo
SpyGlass Pharma Reports Fourth Quarter and Full Year 2025 Earnings and Provides a Corporate Update
2026-03-26 20:05 · Yahoo
SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System
2026-03-09 12:00 · Yahoo
SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit
2026-03-04 13:00 · Yahoo
MongoDB downgraded, Block upgraded: Wall Street's top analyst calls
2026-03-03 14:33 · Yahoo
SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
2026-02-09 21:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.